Abstract
A number of variant cell types are associated with HIV1 transmission and disease progression, including dendritic cells (DCs), macrophages and CD4 lymphocytes. The cell types and their phenotypes associated with infection are still poorly defined and will greatly influence HIV-1 transmission as well as disease progression. The types of immune responses mounted against infectious pathogens will also influence the pool of cells to be infected and thereby influence disease course. We have described CD4 lymphocyte cellular phenotypes induced within the same HIV-1 infected individuals against variant pathogens (namely CMV and TB antigens) and shown that these responses are highly variable. We further demonstrate that their distinctive cytokine and chemokine expression patterns correlate to their HIV-1 infectivity profile both in vitro and in vivo. We have additionally addressed whether viruses produced from variant cellular populations have similar or distinctive phenotypes. Here we show that viruses produced from macrophages opposed to Th1 or Th2 CD4 lymphocytes vary for their interaction with DC-SIGN expressed on DCs and have variant neutralization profiles for 2G12. Furthermore, we have identified a number of host glycopoteins (BSSL and MUC6) that can inhibit HIV-1 from interacting with DCs through binding DC-SIGN. We show that genetic polymorphisms within the BSSL gene can associate with strength of binding to DC-SIGN and that these variants can also be associated with markers of disease progression as well as time to coreceptor switch. In conclusion, the interactions between the adaptive and innate immune response can influence HIV-1 transmission and modulate disease course. Published: 3 October 2011
Highlights
A number of variant cell types are associated with HIV1 transmission and disease progression, including dendritic cells (DCs), macrophages and CD4 lymphocytes
We show that viruses produced from macrophages opposed to Th1 or Th2 CD4 lymphocytes vary for their interaction with DC-SIGN expressed on DCs and have variant neutralization profiles for 2G12
We have identified a number of host glycopoteins (BSSL and MUC6) that can inhibit HIV-1 from interacting with DCs through binding DC-SIGN
Summary
A number of variant cell types are associated with HIV1 transmission and disease progression, including dendritic cells (DCs), macrophages and CD4 lymphocytes. Variant cell types and host glycoproteins influencing HIV-1 infection From Frontiers of Retrovirology 2011 Amsterdam, The Netherlands.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.